Mice with human livers make pharmaceutical testing more accurate

July 12, 2011 by Deborah Braconnier report
Lab mice

(Medical Xpress) -- In a new report published in the Proceedings of the National Academy of Sciences, a team of researchers reveal a new miniature artificial human liver that can be implanted into mice to better enable testing of new drugs and how humans will metabolize them.

When it comes to pharmaceutical research, using mice to test drugs has had its limitations because the of a mouse reacts differently than a human liver. Scientists have been able to make a mouse liver more human-like by injecting into immunodeficient mice with damaged livers.

This new artificial human liver was developed by a team from Massachusetts Institute of Technology and led by biomedical engineer Sangeeta Bhatia. The miniature liver measures 20 millimeters and is implanted into healthy mice.

The human ectopic artificial livers, or HEALS as they call them, are created by co-culturing primary human hepatocytes, or human liver cells, with stabilizing mouse fibroblasts. These cells are then encapsulated using liver and a polymeric scaffold.

The researchers are able to adjust the pore size of the polymer in order to prevent access by the mouse immune system which then allows weeks of testing before possible rejection begins.

The researchers tested the new liver by giving the mice drugs which are metabolized differently by humans and mice such as coumarin (an anticoagulant) and debrisoquine (an antihypertensive). When the mice with the artificial livers received these drugs, they produced metabolites and showed the same metabolic interactions that are normally found in humans.

Current clinical testing of on humans results in 90 percent of drugs failing. This is often due to toxixities that were not discovered in animal preclinical because of the difference in how the mouse liver metabolizes the drug. Researchers hope this new technology will aid in making drug testing safer and discovering these toxicities before they ever get to human clinical trials.

Explore further: Mouse gets human-type immune system

More information: Humanized mice with ectopic artificial liver tissues, PNAS, Published online before print July 11, 2011, doi: 10.1073/pnas.1101791108

Abstract
“Humanized” mice offer a window into aspects of human physiology that are otherwise inaccessible. The best available methods for liver humanization rely on cell transplantation into immunodeficient mice with liver injury but these methods have not gained widespread use due to the duration and variability of hepatocyte repopulation. In light of the significant progress that has been achieved in clinical cell transplantation through tissue engineering, we sought to develop a humanized mouse model based on the facile and ectopic implantation of a tissue-engineered human liver. These human ectopic artificial livers (HEALs) stabilize the function of cryopreserved primary human hepatocytes through juxtacrine and paracrine signals in polymeric scaffolds. In contrast to current methods, HEALs can be efficiently established in immunocompetent mice with normal liver function. Mice transplanted with HEALs exhibit humanized liver functions persistent for weeks, including synthesis of human proteins, human drug metabolism, drug–drug interaction, and drug-induced liver injury. Here, mice with HEALs are used to predict the disproportionate metabolism and toxicity of “major” human metabolites using multiple routes of administration and monitoring. These advances may enable manufacturing of reproducible in vivo models for diverse drug development and research applications.

Related Stories

Keeping hepatitis C virus at bay after a liver transplant

October 1, 2009

One of the most common reasons for needing a liver transplant is liver failure or liver cancer caused by liver cell infection with hepatitis C virus (HCV). However, in nearly all patients the new liver becomes infected with ...

Researchers engineer miniature human livers in the lab

October 30, 2010

Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first ...

Recommended for you

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.